| __timestamp | Exelixis, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50829000 | 2917513 |
| Thursday, January 1, 2015 | 57305000 | 7878291 |
| Friday, January 1, 2016 | 116145000 | 8366794 |
| Sunday, January 1, 2017 | 159362000 | 6610381 |
| Monday, January 1, 2018 | 206366000 | 6556000 |
| Tuesday, January 1, 2019 | 228244000 | 6930000 |
| Wednesday, January 1, 2020 | 293355000 | 8758000 |
| Friday, January 1, 2021 | 401715000 | 10806000 |
| Saturday, January 1, 2022 | 459856000 | 9844000 |
| Sunday, January 1, 2023 | 542705000 | 13481000 |
| Monday, January 1, 2024 | 492128000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Exelixis, Inc. and Soleno Therapeutics, Inc. over a decade, from 2014 to 2023. Exelixis, Inc. has seen a staggering increase in SG&A expenses, growing by over 900% from 2014 to 2023. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Soleno Therapeutics, Inc. maintained a more conservative growth in SG&A expenses, with a 360% increase over the same period. This suggests a more cautious approach to scaling operations. The data highlights the strategic differences between these two companies, offering insights into their operational efficiencies and market strategies. Understanding these trends is essential for investors and stakeholders looking to gauge the financial health and strategic direction of these biotech firms.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and HUTCHMED (China) Limited
Comparing SG&A Expenses: Exelixis, Inc. vs Novavax, Inc. Trends and Insights
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared